New Age Alpha Advisors LLC Purchases Shares of 4,914 DocuSign, Inc. (NASDAQ:DOCU)

New Age Alpha Advisors LLC acquired a new position in DocuSign, Inc. (NASDAQ:DOCU) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 4,914 shares of the company’s stock, valued at approximately $442,000.

A number of other large investors have also recently made changes to their positions in the business. Itau Unibanco Holding S.A. bought a new position in DocuSign in the third quarter worth about $28,000. Kestra Investment Management LLC purchased a new position in shares of DocuSign during the 4th quarter worth approximately $30,000. Modus Advisors LLC bought a new position in shares of DocuSign in the 4th quarter worth approximately $36,000. First Horizon Advisors Inc. lifted its stake in shares of DocuSign by 102.6% in the 4th quarter. First Horizon Advisors Inc. now owns 397 shares of the company’s stock valued at $36,000 after purchasing an additional 201 shares during the period. Finally, Avion Wealth boosted its position in shares of DocuSign by 309.2% during the fourth quarter. Avion Wealth now owns 487 shares of the company’s stock valued at $43,000 after purchasing an additional 368 shares in the last quarter. 77.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, insider James P. Shaughnessy sold 7,500 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $90.17, for a total transaction of $676,275.00. Following the completion of the sale, the insider now directly owns 43,781 shares in the company, valued at approximately $3,947,732.77. The trade was a 14.63 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Teresa Briggs sold 534 shares of the company’s stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $87.41, for a total transaction of $46,676.94. Following the sale, the director now directly owns 8,270 shares of the company’s stock, valued at approximately $722,880.70. This represents a 6.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 97,851 shares of company stock valued at $8,579,369 over the last 90 days. Company insiders own 1.66% of the company’s stock.

DocuSign Stock Performance

DOCU opened at $82.69 on Wednesday. The company’s 50-day simple moving average is $86.84 and its two-hundred day simple moving average is $81.90. DocuSign, Inc. has a 52-week low of $48.70 and a 52-week high of $107.86. The stock has a market capitalization of $16.74 billion, a P/E ratio of 17.05, a P/E/G ratio of 6.94 and a beta of 1.02.

DocuSign (NASDAQ:DOCU) last posted its earnings results on Thursday, March 13th. The company reported $0.86 EPS for the quarter, topping analysts’ consensus estimates of $0.84 by $0.02. The business had revenue of $776.25 million during the quarter, compared to the consensus estimate of $760.94 million. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The firm’s revenue was up 9.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.76 EPS. Research analysts forecast that DocuSign, Inc. will post 1.17 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. Bank of America decreased their price objective on DocuSign from $112.00 to $98.00 and set a “neutral” rating for the company in a report on Friday, March 14th. HSBC reiterated a “reduce” rating on shares of DocuSign in a research note on Friday, December 6th. Royal Bank of Canada reissued a “sector perform” rating and set a $90.00 price objective on shares of DocuSign in a research note on Friday, March 14th. Citigroup upped their price objective on shares of DocuSign from $113.00 to $115.00 and gave the stock a “buy” rating in a report on Friday, March 14th. Finally, JPMorgan Chase & Co. upgraded shares of DocuSign from an “underweight” rating to a “neutral” rating and lifted their target price for the company from $70.00 to $75.00 in a report on Monday, March 10th. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $95.83.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.